Sunshine Biopharma Prices $6M Public Offering at Steep Discount
SBFM sits 37% above its 52-week low of $0.356 on elevated volume (51× avg).
Summary
Sunshine Biopharma priced a $6 million public offering, adding to a string of dilutive financings. The company has been tapping the ATM and warrant exercises, and this new offering comes at a time when the stock trades near $0.49. The offering is likely priced at a discount to market, further pressuring the share price. This follows the $7 million best-efforts offering registered on October 2, indicating continued capital needs. The company's market cap is only about $3 million, so a $6 million raise is highly dilutive to existing shareholders.
At the time of this announcement, SBFM was trading at $0.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3M. The 52-week trading range was $0.36 to $24.30. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.